1. Lehrer S, Rheinstein PH, Rosenzweig KE. Improving the survival of patients with American Joint Committee on Cancer stage III and IV melanoma. Cancer. 2018 Mar 15. doi: 10.1002/cncr.31262. [Epub ahead of print] pdf

  2. Lehrer S, Rheinstein PH. Nasal steroids as a possible treatment for Alzheimer's disease. Discov Med. 2017 Oct;24(132):147-152. PubMed PMID: 29272691. HTML

  3. Lehrer S, Green S, Rosenzweig KE. Risk of malignant brain tumor as a second primary is significantly reduced after treatment of breast cancer. Breast J. 2017 Jul 20. doi: 10.1111/tbj.12880. [Epub ahead of print] pdf

  4. Lehrer S, Rheinstein PH, Rosenzweig KE. Association of Radon Background and Total Background Ionizing Radiation with Alzheimer's Disease Deaths in U.S. States. J Alzheimers Dis. 59:737-741 2017 pdf

  5. Lehrer S, Rosenzweig KE. Influenza Vaccination in Patients With Cancer. Cancer  2017 Apr 1;123(7):1272-1273. pdf

  6. Lehrer S, Rheinstein PH, Green S, Rosenzweig KE. Young premenopausal women with breast cancer, especially estrogen receptor negative, are at significantly increased risk for subsequent ovarian cancer. Discov Med. 2016 Oct;22(121):209-213. html

  7. Lehrer S. and Rheinstein P. A derangement of the brain wound healing process may cause some cases of Alzheimer's disease. Discov Med. 2016 Aug;22(119):43-6.  HTML

  8. Lehrer S, Green S, Rosenzweig KE. Reduced Ovarian Cancer Incidence in Women Exposed to Low Dose Ionizing Background Radiation or Radiation to the Ovaries after Treatment for Breast Cancer or Rectosigmoid Cancer. Asian Pac J Cancer Prev. 2016;17(6):2979-82. pdf

  9. Lehrer S, Green S, Rosenzweig KE. Affluence and Breast Cancer. Breast J. 2016 Jun 14. doi: 10.1111/tbj.12630. [Epub ahead of print] pdf

  10. Lehrer S, Rosenzweig KE. Being a widower may be an indication for routine prostate-specific antigen screening above age 69 years, which the American Urological Association recommends as a cutoff point. Cancer. 2016 Jun 10. doi: 10.1002/cncr.30098. [Epub ahead of print] pdf

  11. Lehrer S, Green S, Rosenzweig KE. Periodontal Disease and Breast Cancer. Cancer Epidemiol Biomarkers Prev May 2016 25:863 pdf

  12. Lehrer S, Green S, Rosenzweig KE. Melanoma Risk and Citrus Consumption. J Clin Oncol. 2016 Feb 20;34(6):636. doi: 10.1200/JCO.2015.63.8254. Epub 2016 Jan 4. HTML

  13. Lehrer S. and Rheinstein P. Relation of Poor Memory to Soluble Tumor Necrosis Factor Receptor Type Two (sTNF-RII). Am J Alzheimers Dis Other Demen. 2015 December pdf

  14. Lehrer S. Continuation of Gradual Weight Gain Necessary for the Onset of Puberty May Be Responsible for Obesity Later in Life. Discovery Medicine, Published on October 28, 2015 HTML pdf

  15. Lehrer S, Green S, Rendo A., Rosenzweig KE. Measles may be a Risk Factor for Malignant Brain Tumors. Brain Tumor Research and Treatment 2015;3(2): 65-67  pdf

  16. Lehrer S. Finasteride for postmenopausal breast cancer prevention. Eur J Cancer Prev. 2015 Sep;24(5):456-7. pdf

  17. Lehrer S. and Rheinstein P. Two compartment model of MSH/ACTH may be a surrogate for intranasal insulin central nervous system kinetics. Journal of Alzheimer's Disease 31 July 2015. pdf  HTML

  18. Lehrer S, Green S, Rosenzweig K. Lack of correlation between benign brain tumors and markers of oral health. New York State Dental Journal 2015; 81(4):41-44. pdf

  19. Lehrer S. Finasteride and dutasteride may reduce melanoma risk. Cancer. 2015 Jun 8. doi: 10.1002/cncr.29520. [Epub ahead of print] pdf

  20. Lehrer S. Adverse Side Effects of Intranasal Detemir Insulin in the SNIFF Trial. Journal of Alzheimer's Disease 4 June 2015. pdf  HTML

  21. Lehrer S, Rosenzweig KE. Wilms tumor and breast cancer. Cancer 121(12) 2099 Jun 15, 2015. pdf

  22. Lehrer S, Rheinstein P, Mulshine J. Inhaled buformin for lymphangioleiomyomatosis and early (airway confined) lung cancer. American Association for Cancer Research Annual Meeting Abstracts 2014;14-A-638-AACR. pdf

  23. Lehrer S, Rosenzweig KE. Lung Cancer Hormesis in High Impact States Where Nuclear Testing Occurred. Clin Lung Cancer. 2014 Oct 13. pii: S1525-7304(14)00227-7. doi: 10.1016/j.cllc.2014.09.010. [Epub ahead of print]. pdf

  24. Steven Lehrer; Sheryl Green; Kenneth E. Rosenzweig; Angela Rendo. No circulating human cytomegalovirus in 14 cases of glioblastoma. Neuro-Oncology 2014; doi: 10.1093/neuonc/nou325. pdf

  25. Lehrer S, Rosenzweig KE. Cold Climate Is a Risk Factor for Thyroid Cancer. Clin Thyroidol 2014;26:273–276.  pdf

  26. Lehrer S, Green S, Rosenzweig KE. Poverty and lung cancer incidence. Cancer. 2014 Aug 5. doi: 10.1002/cncr.28960. [Epub ahead of print] pdf

  27. Lehrer S. and Rheinstein P. Is Alzheimer’s Disease Autoimmune Inflammation of the Brain That Can be Treated With Nasal Nonsteroidal Anti-Inflammatory Drugs? Am J Alzheimers Dis Other Demen.  2015 May;30(3):225-7 pdf

  28. Lehrer, Steven; Green, Sheryl; Martignetti, John A.; Rosenzweig, Kenneth E. Association between breast and thyroid cancers. Advances in Genomics & Genetics. 2014, Vol. 4, p1-3. pdf

  29. Lehrer S. Nasal NSAIDs for Alzheimer's Disease. Am J Alzheimers Dis Other Demen. 2014 Jan 9;29(5):401-403. [Epub ahead of print]. pdf

  30. Lehrer S. Inhaled Thyrotropin-Releasing Hormone for Treatment of Neuropsychiatric Disorders. J Clin Psychopharmacol. 2014 Apr;34(2):288-90 pdf

  31. Lehrer S. Duodenal infusion of feces for recurrent Clostridium difficile. N Engl J Med. 2013 May 30;368(22):2144. PMID: 23718172. pdf

  32. Lehrer S, Green S, Rosenzweig K. Coffee Consumption Associated with Increased Mortality of Women with Breast Cancer. J. Caffeine Res. 2013:3(1) 1-3. pdf

  33. Lehrer S, Green S, Ramanathan L, Rosenzweig K. Insufficient sleep associated with increased breast cancer mortality. Sleep Med. 2013 Mar 4. doi:pii: S1389-9457(12)00384-X. 10.1016/j.sleep.2012.10.012. [Epub ahead of print]. pdf

  34. Lehrer S, Green S, Ramanathan L, Rosenzweig K. Obesity and deranged sleep are independently associated with increased cancer mortality in 50 US states and the District of Columbia. Sleep Breath. 2013 Feb 7. [Epub ahead of print]. pdf

  35. Lehrer S, Green S, Ramanathan L, Rosenzweig K, Rendo A. Virology of Malignant Brain Tumors. EUR ASSOC NEUROONCOL MAG 2013; 3 (Pre-Publishing Online) pdf

  36. Lehrer S, Green S, Ramanathan L, Rosenzweig K. Earlier puberty in boys and rising prostate cancer incidence. Pediatrics. eletter. published online November 1, 2012 pdf

  37. Lehrer S, Green S. Coronary Artery Disease in REDUCE. Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1226. Epub 2012 May 9. pdf

  38. Lehrer S, Green S, Ramanathan L, Rosenzweig K, Labombardi V. No consistent relationship of glioblastoma incidence and cytomegalovirus seropositivity in whites, blacks, and Hispanics. Anticancer Res. 2012 Mar;32(3):1113-5. pdf

  39. Lehrer S. Cytomegalovirus infection in early childhood may be protective against glioblastoma multiforme, while later infection is a risk factor. Med Hypotheses. 2012 May;78(5):657-8. pdf

  40. Lehrer S, Green S, Pessin-Minsley MS. Obesity may protect against benign brain tumors. Med Hypotheses. 2011 Aug;77(2):308. pdf

  41. Lehrer S, Labombardi V, Green S, Pessin-Minsley MS, Germano IM, Rosenzweig KE. No circulating cytomegalovirus in five patients with glioblastoma multiforme. Anticancer Res. 2011 Mar;31(3):959-60. pdf

  42. Lehrer S, Green S, Stock RG. Association between number of cell phone contracts and brain tumor incidence in nineteen U.S. States. J Neurooncol. 2011 Feb;101(3):505-7. Epub 2010 Jun 30. PMID: 20589524 pdf

  43. Lehrer S. Association Between Malaria Incidence and All Cancer Mortality in Fifty U.S. States and the District of Columbia. Anticancer Research 30: 1371-1374 (2010) pdf

  44. Lehrer S. Glioblastoma and dementia may share a common cause. Med Hypotheses 2010; 75:67-68. pdf

  45. Lehrer S. Anopheles mosquito transmission of brain tumor. Med Hypotheses 2010;74(1):167-168. pdf

  46. Lehrer S, André Montazem, Lakshmi Ramanathan, Melissa Pessin-Minsley, John Pfail, Richard G. Stock, Rita Kogan. Bisphosphonate-Induced Osteonecrosis of the Jaws, Bone Markers, and a Hypothesized Candidate Gene. J Oral Maxillofacial Surgery 2009; 67(1):159-161 pdf

  47. Lehrer S. Inhaled insulin for the early detection of lung cancer. Med Hypotheses. 2008;71(4)615-616. pdf

  48. Lehrer S, Montazem A, Ramanathan L, Pessin-Minsley M, Pfail J, Stock RG, Kogan R. Normal serum bone markers in bisphosphonate-induced osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Sep;106(3):389-91. Epub 2008 Jun 13. pdf

  49. Lehrer, S. Statin use to prevent aromatase inhibitor-induced fracture and cardiovascular complications. Med Hypotheses. 2007;68(6)1417. Epub 2006 Dec 29. pdf

  50. Lehrer S, Cesaretti J, Stone NN, Stock RG. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation. BJU Int. 2006 Nov;98(5):979-81. pdf

  51. Lehrer S, Diamond EJ, Stone NN, Stock RG. Serum thyroid-stimulating hormone is elevated in men with Gleason 8 prostate cancer. BJU Int. 2005; 96, 328–329. pdf

  52. Lehrer S, Diamond EJ, Mamkine B, Droller MJ, Stone NN and Stock RG. C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancer. BJU Int. 2005; 95, 961–962. pdf

  53. Cesaretti JA, Stock RG, Lehrer S, Atencio DA, Bernstein JL, Stone NN, Wallenstein S, Green S, Loeb K, Kollmeier M, Smith M, Rosenstein BS. ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer. Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):196-202. pdf

  54. Lehrer S, Stone NN, Stock RG. Prostate cancer in a large prostate is associated with a decreased prostate specific antigen failure rate after brachytherapy. 2005; J Urol 173:79-81. pdf

  55. Lehrer S, Diamond EJ, Mamkine B, Stone NN, Stock RG. Serum interleukin-8 is elevated in men with prostate cancer and bone metastases. Technology in Cancer Research & Treatment. 2004; 3(5):411-412.  pdf

  56. Lehrer S, Roboz J, Ding H, Zhao S, Diamond EJ, Holland JF, Stone NN, Droller MJ, Stock RG. Putative protein markers in the sera of men with prostatic neoplasms. BJU Int 2003 Aug;92(3):223-5.  pdf

  57. Lehrer S, Diamond EJ, Stone NN, Droller MJ, Stock RG, Stone M, Bajwa A, Kornreich R. Elevated serum triiodothyronine (t3) in Ashkenazi Jewish prostate cancer patients carrying the I1307k allele of the APC (adenopolyposis coli) gene. Urol Oncol 2003 Mar-Apr;21(2):101-4. pdf

  58. Lehrer S, Diamond EJ, Droller MJ, Stone NN, Stock RG. Re: Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst 2002 Dec 18;94(24):1893. pdf

  59. Lehrer S, Diamond EJ, Stagger S, Stone NN, Stock RG. Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer. Br J Cancer 2002 Sep 23;87(7):726-8. pdf

  60. Lehrer S. Reply: Prostate cancer, insulin and androgen deprivation therapy. Br J Cancer 2003 Nov 3;89(9):1815. pdf

  61. Lehrer S, Diamond EJ, Stagger S, Stone NN, Stock RG. Increased serum insulin associated with increased risk of prostate cancer recurrence. The Prostate 2002;50:1-3. pdf

  62. Lehrer S, Stone NN, Droller MJ, Stock RG. Association between American Urologic Association (AUA) urinary symptom score and disease stage in men with localized prostate cancer. Urol Oncol 2002;7(2):73-76. pdf

  63. Lehrer S, Diamond EJ, Stone NN, Droller MJ, Stock RG. Serum triiodothyronine is increased in men with prostate cancer and benign prostatic hyperplasia. Journal of Urology 2002;168:2431-2433. pdf

  64. Lehrer S, Diamond EJ, Bajwa AW, Kornreich R, Stagger S, Stone NN, Droller MJ, Stock RG. Association between serum triiodothyronine (t3) level and risk of disease recurrence in men with localized prostate cancer. Prostate Cancer and Prostatic Diseases 2001;4:232-234. pdf

  65. Lehrer S, McCurdy LD, Stock RG, Kornreich R, Stone NN, Eng C. Body mass, age, and the APC I1307K allele in Ashkenazi Jewish prostate cancer patients. Cancer Genet Cytogenet 2000;122:131-133. pdf

  66. Lehrer S. Re: Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients. J Urol 1998;159:1311. pdf

  67. Lehrer S, Fodor F, Stock RG, Stone NN, Eng C, Song HK, McGovern M. Absence of 185delAG mutation of the BRCA1 gene and 617delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer. Brit J Cancer 1998;78(6):771-773. pdf

  68. Lehrer S. Possible relationship of the apolipoprotein E (ApoE) epsilon4 allele to prostate cancer. Br J Cancer 1998;78:1398. pdf

  69. Lehrer S. Pregnancy termination and risk of breast cancer. JAMA 1996;276:31-2. pdf

  70. Lehrer S, Terk M, Piccoli SP, Song HK, Lavagnini P, Luderer AA. Reverse transcriptase-polymerase chain reaction for prostate-specific antigen may be a prognostic indicator in breast cancer. Br J Cancer 1996;74:871-873. pdf

  71. Brower ST, Tartter P, Weiss S, Luderer AA, Lehrer S. Breast cancer and family history: levels of lipid-associated sialic acid in plasma and absent family history of breast cancer in women who have breast tumors. Mt Sinai J Med 1995;62:419-21. pdf

  72. Brower ST, Tartter P, Weiss S, Luderer AA, Lehrer S. Reproductive history and prognosis in patients with operable breast cancer. Cancer 1995;76:531-532. pdf

  73. Lehrer S, Lee P, Tartter P, Shank B, Brower ST. Breast cancer and family history: a multivariate analysis of levels of tumor HER2 protein and family history of cancer in women who have breast cancer. Mt Sinai J Med 1995;62:415-8. pdf

  74. Lehrer S, Garey J, Shank B. Nomograms for determining the probability of axillary node involvement in women with breast cancer. J Cancer Res Clin Oncol 1995;121:123-125. pdf

  75. Berkowitz GS, Stone JL, Lehrer SP, Marcus M, Lapinski RH, Schachter BS. An estrogen receptor genetic polymorphism and the risk of primary and secondary recurrent spontaneous abortion. Am J Obstet Gynecol 1994;171(6):1579-1584.  pdf

  76. Garey J, Lehrer S. Adjuvant therapy for breast cancer. N Engl J Med 1994;331(11):742-743. pdf

  77. Lehrer S, Harlap S, Rabin J, Schachter BS. Estrogen receptor polymorphism, spontaneous abortion, and breast cancer risk. Int J Oncol 1994;5:861-864. abstract  pdf

  78. Lehrer S. Fostering young investigators [letter]. Science 1994;266:954 pdf

  79. Lehrer S, Song HK. Nomogram for predicting the risk of node involvement in prostate cancer, given pretreatment prostate-specific antigen and Gleason score [letter]. Int J Radiat Oncol Biol Phys 1994;30:509-510. pdf

  80. Lehrer S. Tubal ligation, hysterectomy, and risk of ovarian cancer [letter; comment]. JAMA 1994;271:1236. pdf

  81. Lehrer S, Bogursky E, Yemini M, Kase NG, Birkenfeld A. Gynecologic manifestations of Sjogren's syndrome. Am J Obstet Gynecol 1994;170:835-837. pdf

  82. Lehrer S, Rabin J, Stone J, Berkowitz GS. Association of an estrogen receptor variant with increased height in women. Horm Metab Res 1994;26:486-488. pdf

  83. Schachter BS, Lehrer S. Re: "Risk of miscarriage and a common variant of the estrogen receptor gene" [letter]. Am J Epidemiol 1994;140:1144-1145. pdf

  84. Lehrer S, Segna R, Dottino P, Cohen C. Lipid associated sialic acid in plasma (LASA-P), plasma DM/70K, tumor epidermal growth factor and tumor DNA index in women with ovarian cancer. Int J Oncol 1993;2:95-96. abstract  pdf

  85. Lehrer S, Rabin J, Kalir T, Schachter B. Estrogen receptor variant and hypertension in women. Hypertension 1993;21:439-441. pdf  citations

  86. Lehrer S, Lee P, Tartter P, Brower S. Tumour HER2 protein in breast cancer and family history. Lancet 1993;341:1420-1421. pdf

  87. Lehrer S, Stone J, Lapinski R, Lockwood CJ, Schachter BS, Berkowitz R, Berkowitz GS. Association between pregnancy-induced hypertension and asthma during pregnancy. Am J Obstet Gynecol 1993;168(5):1463-1466. pdf

  88. Lehrer S. Reply to Fossati et al. Cancer 1993;71(3):877

  89. Lehrer SP, Schmutzler RK, Rabin JM, Schachter BS. An estrogen receptor genetic polymorphism and a history of spontaneous abortion--correlation in women with estrogen receptor positive breast cancer but not in women with estrogen receptor negative breast cancer or in women without cancer. Breast Cancer Res Treat 1993;26:175-180. pdf

  90. Lehrer S, Levine E, Savoretti P, Cropley J, Botstein C, Song HK, Mandell L, Shank B. Past pregnancy is associated with axillary node involvement in women with breast cancer. Cancer 1992;69:981-983. pdf

  91. Lehrer S, Levine E, Savoretti P, Cropley J, Dalton J, Song HK, Thung SN, Rabinowitz J, Mandell L. Diminished ratio of estrogen receptors to progesterone receptors in breast carcinomas of women who have had multiple miscarriages. Mount Sinai J Med (NY) 1992;59:28-31. pdf

  92. Lehrer S, Levine E, Savoretti P, Cropley J, Thung SN, Mandell L, Shank B. Oestrogen and progesterone receptor dissociation and family history of breast cancer. Lancet 1992;339:1108-1109. pdf

  93. Macri P, Khoriaty G, Lehrer S, Karurunaratne A, Milne C, Schachter B. Sequence of a human estrogen receptor variant allele. Nucleic Acids Research 1992;20:2008 pdf

  94. Lehrer S, Levine E, Savoretti P, Cropley J, Song HK, Mandell LR, Shank B. Association of increased body mass index with diminished tumor estrogen receptor (ER) level in breast cancer patients younger than 50 years of age with ER-positive tumors. Cancer 1991;68:2489. pdf

  95. Schmutzler RK, Sanchez M, Lehrer S, Chaparro CA, Phillips C, Rabin J, Schachter B. Incidence of an estrogen receptor polymorphism in breast cancer patients. Breast Cancer Res Treat 1991;19:111-117. pdf

  96. Lehrer S, Sanchez M, Song HK, Dalton J, Levine E, Savoretti P, Thung SN, Schachter BS. Oestrogen receptor B-region polymorphism and spontaneous abortion in women with breast cancer. Lancet 1990;335:622-624. pdf

  97. Mencken the Welch-Basher. Hopkins Medical News. Summer 1990, p 3. pdf

  98. Garcia T, Sanchez M, Cox JL, Shaw PA, Ross JBA, Lehrer S, Schachter B. Identification of a variant form of the human estrogen receptor with an amino acid replacement. Nucleic Acids Research 1989;17:8364  pdf

  99. Lehrer S, O'Shaughnessy J, Song HK, Levine E, Savoretti P, Dalton J, Lipsztein R, Kalnicki S, Bloomer WD. Activity of pp60c-src protein kinase in human breast cancer. Mt Sinai J Med 1989;56:83-5. pdf

  100. Lehrer S, Diamond E, Song HK, Bloomer WD, Blumenthal R. Diminished corticosterone levels in nude mice implanted with MCF-7 or ZR-75-1 human breast tumor cells. Arch Gynecol Obstet 1989;245:704-7. pdf

  101. Garcia T, Lehrer S, Bloomer WD, Schachter B. A variant estrogen receptor messenger ribonucleic acid is associated with reduced levels of estrogen binding in human mammary tumors. Mol Endocrinol 1988;2:785-91. pdf

  102. Lehrer S, Brown RR, Lee C, Kalnicki S, Lipsztein R, Bloomer WD. Neuroendocrine abnormalities and the pathogenesis of estrogen-receptor-positive breast cancer. Mt Sinai J Med 1988;55:272-5. abstract  pdf

  103. Lehrer S, Brown RR, Lee CM, Song HK, Kalnicki S, Lipsztein R, Dalton J, Bloomer WD. Tryptophan metabolism in women with breast cancer. Int J Cancer 1988;42:137. pdf

  104. Lehrer S, Levine E, Song HK, Bloomer WD. Breast size, endogenous estrogens, and breast cancer: a review with hypothesis. Mt Sinai J Med 1988;55:142-3. abstract  pdf

  105. Lehrer S. Rats on 22.5-hr light:dark cycles have vaginal opening earlier than rats on 26-hr light:dark cycles. J Pineal Res 1986;3:375-8.  abstract  pdf

  106. Lehrer S, Levine E, Bloomer WD. Abnormally diminished sense of smell in women with oestrogen receptor positive breast cancer. Lancet 1985;2:333.  pdf

  107. Lehrer S. Puberty and menopause in the human: possible relation to gonadotropin-releasing-hormone pulse frequency and the pineal gland. Pineal Research Reviews 1985;3:237-257. pdf

  108. Lehrer S. Modern correlates of Freudian psychology. Infant sexuality and the unconscious. Am J Med 1984;77:977-80. pdf

  109. Lehrer S. Puberty and resonance: a hypothesis. Mt Sinai J Med 1983;50:39-43. abstract  pdf

  110. Lehrer S. Fertility of blind women. Fertil Steril 1982;38:751-2. pdf

  111. Lehrer S. Life change and lung cancer. J Human Stress 1981;7:7-11. abstract  pdf

  112. Lehrer S. Twenty-one hour light-dark cycle accelerates vaginal opening in the rat. Bull N Y Acad Med 1981;57:705-8. pdf

  113. Lehrer S. Fertility and menopause in blind women. Fertil Steril 1981;36:396-8. pdf

  114. Lehrer S. Blindness increases life span of male rats: pineal effect on longevity. J Chronic Dis 1981;34:427-9. pdf

  115. Lehrer S. Telltale looks. Forbes. April 13, 1981. pdf

  116. Lehrer S. Life change and gastric cancer. Psychosom Med 1980;42:499-502. abstract  pdf

  117. Lehrer S. Clinical trial of rectal self-examination. Arch Intern Med 1979;139:1194.  pdf

  118. Lehrer S. Possible pineal-suprachiasmatic clock regulation of development and life span. Arch Ophthalmol 1979;97:359.

  119. Lehrer S. Pineal effect on longevity. J Chronic Dis 1979;32:411-2. pdf

  120. Lehrer S, Yoo OH, Roswit B, Jothikumar T. Mycosis fungoides with pulmanary manifestations. Mt Sinai J Med 1978;45:748-53.

  121. Lehrer S. Rectal self-examination. Am J Dig Dis 1978;23:572-3.

  122. Bryk D, Lehrer S. Successive abdominal roentgenograms: a new method of evaluating postoperative small bowel activity. Invest Radiol 1977;12:520-6.

  123. Lehrer S, Roswit B. Letter: Giant cell tumor of the temporal bone. Arch Neurol 1976;33:663.

  124. Lehrer S, Roswit B, Federman Q. The presentation of malignant lymphoma in the oral cavity and pharynx. Oral Surg Oral Med Oral Pathol 1976;41:441-50.